An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
male in Escherichia coli str. K-12 substr. MG1655Salmonella enterica subsp. enterica serovar Typhimurium str. LT2Thermococcus litoralis DSM 5473All 284 Gene records
Therapies for Clinically Localized Prostate Cancer [Internet].
Dahm P, Brasure M, Ester E, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Sep. (Comparative Effectiveness Review, No. 230.)
Top results in this bookTable of Contents
Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review [Internet].
Sun F, Oyesanmi O, Fontanarosa J, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec. (Comparative Effectiveness Reviews, No. 146.)
Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].
Fenton JJ, Weyrich MS, Durbin S, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May. (Evidence Synthesis, No. 154.)
Treatments for Localized Prostate Cancer: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation [Internet].
Chou R, Dana T, Bougatsos C, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Oct. (Evidence Syntheses, No. 91.)
PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 98 [Internet].
Gutman SI, Oliansky DM, Belinson S, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Apr. (Future Research Needs Papers, No. 24.)
Future Research Needs for Comparative Effectiveness of Treatments of Localized Prostate Cancer: Identification of Future Research Needs from Comparative Effectiveness Review No. 13 [Internet].
Rothenberg BM, Marbella A, Belinson SE, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2010 Sep. (Future Research Needs Papers, No. 4.)
Radium-223 for Patients with Castration Resistant Prostate Cancer with Bone Metastases: A Review of Clinical Effectiveness, Cost-effectiveness and Guidelines [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Oct 31.
Prostate-Specific Antigen-Based Screening for Prostate Cancer: An Evidence Update for the U.S. Preventive Services Task Force [Internet].
Lin K, Croswell JM, Koenig H, et al.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Oct. (Evidence Syntheses, No. 90.)
NTP Genetically Modified Model Report on the Toxicology Studies of Aspartame (CASRN 22839-47-0) in Genetically Modified (FVB Tg.AC Hemizygous) and B6.129-Cdkn2atm1Rdp (N2) Deficient Mice and Carcinogenicity Studies of Aspartame in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Feed Studies): NTP GMM 01 [Internet].
Bucher JR, Bristol DW, French JE, et al.
Research Triangle Park (NC): National Toxicology Program; 2005 Oct.
Prostate Cancer Screening: A Review of the Guidelines [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2013 Nov 29.
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
Hydrogel Spacers for Patients with Prostate Cancer: A Review of Clinical Effectiveness and Cost-Effectiveness [Internet].
Chao YS, MacDougall D, de Nanassy A.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb 22.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2026 Jan-.
Magnetic Resonance Imaging for Prostate Assessment: A Review of Clinical and Cost-Effectiveness [Internet].
Chiu S, Adcock L.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Sep 5.
PET Diagnostic Imaging with Prostate-Specific Membrane Antigen for Prostate Cancer: A Review of Clinical Utility, Cost-Effectiveness, Diagnostic Accuracy, and Guidelines [Internet].
Edge R, Picheca L.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Nov 17.
NTP Genetically Modified Model Report on the Toxicology Studies of Bromodichloromethane (CASRN 75-27-4) in Genetically Modified (FVB Tg.AC Hemizygous) Mice (Dermal, Drinking Water, and Gavage Studies) and Carcinogenicity Studies of Bromodichloromethane in Genetically Modified [B6.129-Trp53tm1Brd (N5) Haploinsufficient] Mice (Drinking Water and Gavage Studies): NTP GMM 05 [Internet].
Boorman GA, Herbert RA, Bristol DW, et al.
Research Triangle Park (NC): National Toxicology Program; 2007 May.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Endotext [Internet].
Feingold KR, Adler RA, Ahmed SF, et al., editors.
South Dartmouth (MA): MDText.com, Inc.; 2000-.
Androgen Receptor Targeted Agents for Castration Resistant Prostate Cancer: A Review of Clinical Effectiveness and Cost-Effectiveness [Internet].
Tran K, McCormack S.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun 6.
High Dose Rate Brachytherapy versus Low Dose Rate Brachytherapy for the Treatment of Prostate Cancer: A Review of Clinical Effectiveness and Cost-Effectiveness [Internet].
Gray C, Campbell K.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb 14.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on